WAM
EUCRU

Wolverine Asset Management’s Eucrates Biomedical Acquisition Corp. Unit EUCRU Stock Holding History

Wolverine Asset Management’s Portfolio EUCRU Stock Details EUCRU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-2,635
Closed -$26.3K – 2430
2022
Q4 		$26.3K Sell
2,635
-1,275
-33% -$12.7K ﹤0.01% 1483
2022
Q3 		$39K Sell
3,910
-90
-2% -$897 ﹤0.01% 1664
2022
Q2 		$40K Hold
4,000
– – ﹤0.01% 1636
2022
Q1 		$39K Buy
+4,000
New +$39.7K ﹤0.01% 1594
2021
Q2 		– Sell
-1,107
Closed -$11K – 2615
2021
Q1 		$11K Sell
1,107
-2,253
-67% -$24K ﹤0.01% 1860
2020
Q4 		$35K Buy
+3,360
New +$34.1K ﹤0.01% 1385

Other funds holding EUCRU

Verition Fund Management
Verition Fund Management Greenwich, Connecticut $10.3B AUM 30.69% 1-Year Est. Return
SCM
Sio Capital Management New York $694M AUM 79.73% 1-Year Est. Return
CS
Clear Street New York $17.8B AUM 56.26% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return